To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene DUSP14TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
207 supporting clones for gene DUSP14 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR623161 HeLa cells Cot 25-normalized .a 1 to 1503 1 to 1503 exact tiling clone,   1503/1503
(100 %)
0 diff
(100 %id)
AL556535 placenta .a 1 to 916 1 to 903 S19A P20R Q21R K22S P23R ... fully sequenced,   903/903
(100 %)
9 diff
(99.1 %id)
TI_57232130   .a 6 to 853 28 to 876       849/876
(96 %)
9 diff
(99.0 %id)
BI906249 leukocyte .a 8 to 853 1 to 841       841/841
(100 %)
7 diff
(99.2 %id)
AL525672 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 9 to 680 1 to 666       666/754
(88 %)
7 diff
(99.1 %id)
CR598453 Placenta Cot 25-normalized .a 15 to 1522 1 to 1508       1508/1508
(100 %)
0 diff
(100 %id)
AL543561 placenta, Placenta Cot 25-normalized .a 15 to 720 1 to 702   fully sequenced,   702/702
(100 %)
3 diff
(99.6 %id)
NM_007026.2   .a 15 to 1522 1 to 1508   RefSeq,   1508/1508
(100 %)
0 diff
(100 %id)
BX331883 Neuroblastoma Cot 25-normalized .a 22 to 191 65 to 228       164/228
(71 %)
7 diff
(97.0 %id)
CR608141 T cells (Jurkat cell line) Cot10-normalized .a 27 to 1501 1 to 1475       1475/1475
(100 %)
0 diff
(100 %id)
AL559556 T cells from T cell leukemia .a 27 to 805 1 to 772       772/772
(100 %)
5 diff
(99.4 %id)
BX402875   .a 27 to 979 1 to 919       919/983
(93 %)
36 diff
(96.4 %id)
BP321932 Pancreas .a 34 to 601 1 to 563       563/563
(100 %)
3 diff
(99.5 %id)
CR599138 T cells (Jurkat cell line) Cot10-normalized .a 42 to 1499 1 to 1458       1458/1458
(100 %)
0 diff
(100 %id)
AL559509 T cells from T cell leukemia .a 42 to 742 1 to 700   fully sequenced,   700/700
(100 %)
18 diff
(97.5 %id)
TI_57181871   .a 58 to 954 28 to 919       890/919
(96 %)
14 diff
(98.5 %id)
BE393505 endometrium, adenocarcinoma cell line, uterus .a 60 to 747 1 to 674       674/679
(99 %)
15 diff
(97.8 %id)
AK314894   .a 61 to 905 1 to 840       840/840
(100 %)
1 diff
(99.9 %id)
DA029313   .a 62 to 614 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
CD701726 normal nasopharynx .a 62 to 636 15 to 590       576/590
(97 %)
7 diff
(98.9 %id)
BX952512   .a 62 to 334 1 to 270       270/270
(100 %)
2 diff
(99.3 %id)
W23811 senescent fibroblast .a 62 to 523 1 to 465       463/465
(99 %)
17 diff
(96.4 %id)
BP218505 caudate nucleus .a 63 to 538 1 to 472       472/476
(99 %)
8 diff
(98.4 %id)
BX473339   .a 63 to 795 1 to 730       730/730
(100 %)
7 diff
(99.1 %id)
BU601746 mixed (pool of 40 RNAs) .a 63 to 882 1 to 821       821/821
(100 %)
24 diff
(97.1 %id)
AU100110   .a 63 to 367 1 to 300       300/300
(100 %)
4 diff
(98.7 %id)
AU107255   .a 63 to 112 1 to 50       50/50
(100 %)
2 diff
(96.0 %id)
BP292712 lung .a 63 to 640 1 to 573       573/573
(100 %)
4 diff
(99.4 %id)
BP297763   .a 63 to 643 1 to 576       576/576
(100 %)
2 diff
(99.7 %id)
BP380355 uterus .a 63 to 644 1 to 577       577/577
(100 %)
2 diff
(99.7 %id)
DA361008 subthalamic nucleus .a 64 to 623 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
BX473314   .a 64 to 748 1 to 680       680/680
(100 %)
1 diff
(99.9 %id)
BG116518 duodenal adenocarcinoma, cell line, small intestine .a 66 to 855 1 to 785       785/845
(92 %)
12 diff
(98.6 %id)
BI768742 pooled lung and spleen .a 67 to 954 1 to 884       884/884
(100 %)
8 diff
(99.1 %id)
TI_45379113   .a 68 to 954 58 to 943       886/943
(93 %)
21 diff
(97.8 %id)
TI_45379289   .a 68 to 921 66 to 923       858/1012
(84 %)
23 diff
(97.8 %id)
TI_57219418   .a 68 to 867 59 to 855       797/855
(93 %)
14 diff
(98.4 %id)
BC001894 Lung, small cell carcinoma .a 69 to 1528 1 to 1454   tiling clone, available from MGC, AAA   1454/1454
(100 %)
2 diff
(99.9 %id)
AF038844   .a 71 to 1528 1 to 1452   AAA   1452/1452
(100 %)
4 diff
(99.8 %id)
CR603252 Neuroblastoma Cot 25-normalized .a 72 to 1516 1 to 1445       1445/1445
(100 %)
0 diff
(100 %id)
AL525250 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 72 to 851 1 to 757   fully sequenced,   757/757
(100 %)
6 diff
(99.3 %id)
BM928368 brain .a 72 to 1141 11 to 1095       1085/1095
(99 %)
49 diff
(95.6 %id)
TI_57198581   .a 72 to 1011 28 to 968       941/968
(97 %)
23 diff
(97.7 %id)
BQ638789 eye, retina .a 73 to 689 11 to 627       617/627
(98 %)
6 diff
(99.1 %id)
BG470704 eye, retinoblastoma .a 73 to 845 1 to 768       768/768
(100 %)
2 diff
(99.8 %id)
BQ939586 large cell carcinoma, lung .a 74 to 961 1 to 892       892/949
(93 %)
13 diff
(98.7 %id)
BI821884 pooled brain, lung, testis .a 75 to 1011 1 to 932       932/932
(100 %)
19 diff
(98.0 %id)
CN346356 embryonic stem cells, DMSO-treated H9 cellline .a 76 to 843 1 to 768       768/768
(100 %)
0 diff
(100 %id)
R14800 whole brain .a 76 to 483 1 to 410       408/415
(98 %)
20 diff
(95.2 %id)
BI488551 brain .a 76 to 954 1 to 879       879/879
(100 %)
15 diff
(98.3 %id)
BI488652 brain .a 76 to 1008 1 to 940       940/940
(100 %)
25 diff
(97.4 %id)
BI757711 brain .a 76 to 867 1 to 790       790/790
(100 %)
8 diff
(99.0 %id)
AA304904 colon .a 77 to 436 1 to 356       356/356
(100 %)
3 diff
(99.2 %id)
AA307000 colon .a 77 to 512 1 to 437       437/437
(100 %)
4 diff
(99.1 %id)
BQ654378 hepatocellular carcinoma, cell line, Liver .a 77 to 828 23 to 775       753/987
(76 %)
26 diff
(97.4 %id)
BI334730 cervical carcinoma cell line, cervix .a 78 to 787 1 to 707       707/707
(100 %)
3 diff
(99.6 %id)
R59757 whole brain .a 79 to 546 1 to 472       472/476
(99 %)
17 diff
(96.5 %id)
DN993874 brain, whole brain .a 79 to 664 3 to 589       587/589
(99 %)
5 diff
(99.2 %id)
BE791258 lung, small cell carcinoma .a 81 to 883 1 to 805       805/1145
(70 %)
21 diff
(98.2 %id)
CN346357 embryonic stem cells, DMSO-treated H9 cellline .a 82 to 824 1 to 739       739/740
(99 %)
3 diff
(99.6 %id)
BE122894 skin .a 88 to 573 1 to 481       481/481
(100 %)
8 diff
(98.4 %id)
Z42261 brain, total brain .a 88 to 332 1 to 239       239/239
(100 %)
5 diff
(98.0 %id)
BE263494 lung, small cell carcinoma .a 88 to 648 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BG288318 bladder, transitional cell papilloma, cell line .a 88 to 856 1 to 759       759/764
(99 %)
13 diff
(98.3 %id)
CF272245 Brain glioblastoma .a 88 to 907 1 to 820       820/841
(97 %)
2 diff
(99.8 %id)
CA489579   .a 89 to 956 1 to 874       874/876
(99 %)
11 diff
(98.8 %id)
CD514442 White Matter .a 89 to 970 1 to 878       878/878
(100 %)
6 diff
(99.4 %id)
BU165903 melanotic melanoma, skin .a 91 to 951 1 to 864       864/865
(99 %)
4 diff
(99.6 %id)
BE744880 adenocarcinoma cell line, ovary .a 95 to 898 1 to 798       798/944
(84 %)
15 diff
(98.5 %id)
AA336671 endometrium .a 96 to 474 1 to 375       373/375
(99 %)
7 diff
(98.2 %id)
AA362638 ovary .a 97 to 332 1 to 238       238/239
(99 %)
8 diff
(96.7 %id)
R25047 whole brain .a 98 to 463 1 to 364       362/365
(99 %)
12 diff
(96.8 %id)
BC000370 Lung, small cell carcinoma .a 99 to 1531 1 to 1427   available from MGC, AAA   1427/1427
(100 %)
2 diff
(99.9 %id)
BC004448 Lung, small cell carcinoma .a 99 to 1531 1 to 1427   available from MGC, AAA   1427/1427
(100 %)
2 diff
(99.9 %id)
CD242619 brain, Pituitary .a 99 to 942 32 to 884       853/922
(92 %)
26 diff
(97.2 %id)
BE409430 choriocarcinoma, placenta .a 100 to 759 1 to 662       662/697
(94 %)
22 diff
(96.9 %id)
CN346355 embryonic stem cells, cell lines H1, H7, andH9 .a 111 to 774 3 to 666       664/666
(99 %)
0 diff
(100 %id)
BG180393 adenocarcinoma, cell line, Prostate .a 122 to 782 19 to 671       653/929
(70 %)
18 diff
(98.1 %id)
BF219817 lung, small cell carcinoma .a 123 to 588 1 to 466       466/466
(100 %)
0 diff
(100 %id)
CR595784 placenta .a 124 to 1524 1 to 1401       1401/1401
(100 %)
0 diff
(100 %id)
CR604963 Neuroblastoma Cot 25-normalized .a 124 to 1518 1 to 1395       1395/1395
(100 %)
0 diff
(100 %id)
CR623101 fetal brain .a 124 to 1517 1 to 1394       1394/1394
(100 %)
0 diff
(100 %id)
CR623231 Placenta Cot 25-normalized .a 124 to 1532 1 to 1409       1409/1409
(100 %)
0 diff
(100 %id)
CR625439 HeLa cells Cot 25-normalized .a 124 to 1496 1 to 1373       1373/1373
(100 %)
0 diff
(100 %id)
AL527826 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 124 to 909 1 to 775   fully sequenced,   775/775
(100 %)
2 diff
(99.8 %id)
BX417589 placenta .a 124 to 1174 1 to 1034       1034/1038
(99 %)
30 diff
(97.2 %id)
AL539329 brain, fetal brain .a 124 to 491 1 to 365   fully sequenced,   365/365
(100 %)
4 diff
(99.0 %id)
BX343955 Placenta Cot 25-normalized .a 124 to 1182 1 to 1049       1049/1053
(99 %)
26 diff
(97.6 %id)
BX397601 Placenta Cot 25-normalized .a 124 to 1175 1 to 1046       1046/1046
(100 %)
15 diff
(98.6 %id)
AL556367 placenta .a 124 to 630 1 to 494   fully sequenced,   494/494
(100 %)
0 diff
(100 %id)
AW247456 lung, small cell carcinoma .a 124 to 732 29 to 638       608/638
(95 %)
23 diff
(96.4 %id)
BI758457 brain .a 124 to 875 47 to 799       753/799
(94 %)
7 diff
(99.2 %id)
TI_57215389   .a 124 to 875 47 to 799       753/799
(94 %)
7 diff
(99.2 %id)
BG424624 Kidney, renal cell adenocarcinoma .a 128 to 742 91 to 709       619/881
(70 %)
17 diff
(98.1 %id)
BG113495 Bone, osteosarcoma, cell line .a 209 to 955 2 to 748       747/806
(92 %)
17 diff
(97.9 %id)
BP249269 Kidney .a 257 to 838 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BE869720 adenocarcinoma, colon .a 275 to 991 1 to 706       706/909
(77 %)
17 diff
(98.2 %id)
AA126103 colon, tumor .a 279 to 692 1 to 414       414/414
(100 %)
0 diff
(100 %id)
AF120032   .a 307 to 1461 1 to 1151   AAA   1151/1151
(100 %)
4 diff
(99.7 %id)
CR536500   .a 309 to 905 1 to 597       597/597
(100 %)
0 diff
(100 %id)
CR541800   .a 309 to 902 1 to 594       594/594
(100 %)
0 diff
(100 %id)
CV025447 mixed .a 309 to 891 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
TI_1948090201   .a 309 to 844 117 to 654       538/1416
(37 %)
20 diff
(98.6 %id)
AV684123 hepatocellular carcinoma .a 318 to 715 1 to 392       392/397
(98 %)
9 diff
(97.8 %id)
AV683070 hepatocellular carcinoma .a 318 to 720 1 to 403       403/414
(97 %)
0 diff
(100 %id)
CR606946 Neuroblastoma Cot 25-normalized .a 348 to 1527 1 to 1180       1180/1180
(100 %)
0 diff
(100 %id)
BX332031 Neuroblastoma Cot 25-normalized .a 348 to 1325 1 to 970       970/970
(100 %)
16 diff
(98.4 %id)
BF130916 hypernephroma, Kidney .a 353 to 955 1 to 600       600/876
(68 %)
10 diff
(98.9 %id)
CT004795 T-Lymphocytes .a 381 to 1181 1 to 803       803/809
(99 %)
5 diff
(99.4 %id)
BE706039 head_neck .a 389 to 783 1 to 402       402/472
(85 %)
9 diff
(98.1 %id)
BE867581 adenocarcinoma, colon .a 397 to 1180 1 to 773       773/812
(95 %)
25 diff
(97.0 %id)
BG765121 melanotic melanoma, high MDR (cell line), skin .a 446 to 1079 1 to 634       634/634
(100 %)
3 diff
(99.6 %id)
AL567789 brain, fetal brain .a 461 to 1517 1051 to 1   fully sequenced,   1051/1051
(100 %)
14 diff
(98.7 %id)
AA297955 Prostate .a 477 to 734 1 to 258       258/258
(100 %)
0 diff
(100 %id)
BM849784 myeloma .a 477 to 1032 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
CR743935 pooled germ cell tumors .a 478 to 962 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
BX343954 Placenta Cot 25-normalized .a 479 to 1504 1018 to 1       1018/1064
(95 %)
18 diff
(98.4 %id)
BQ898275 epidermoid carcinoma, cell line, salivary gland .a 480 to 1361 1 to 889       889/889
(100 %)
29 diff
(96.8 %id)
BQ900741 eye, normal pigmented retinal epithelium .a 490 to 1022 4 to 540       537/980
(54 %)
14 diff
(98.6 %id)
BG675677 skin, squamous cell carcinoma .a 502 to 1318 1 to 820       820/820
(100 %)
11 diff
(98.7 %id)
TI_149296263   .a 503 to 1536 1083 to 84   AAA   1000/1000
(100 %)
40 diff
(96.0 %id)
BQ009199 Chondrosarcoma, Left Pubic Bone .a 519 to 1092 598 to 25   AAA   574/588
(97 %)
0 diff
(100 %id)
AW958991   .a 532 to 1187 1 to 659       659/661
(99 %)
54 diff
(91.9 %id)
AA298046   .a 538 to 876 1 to 343       343/345
(99 %)
13 diff
(96.3 %id)
W30715 senescent fibroblast .a 574 to 1164 1 to 594   fully sequenced,   594/594
(100 %)
13 diff
(97.9 %id)
TI_154050372   .a 578 to 1531 1032 to 91   AAA   942/1037
(90 %)
24 diff
(97.7 %id)
AL556366 placenta .a 600 to 1496 891 to 1   fully sequenced,   891/891
(100 %)
1 diff
(99.9 %id)
BX402874   .a 622 to 1502 880 to 1       880/1011
(87 %)
41 diff
(96.0 %id)
BX454510 placenta .a 637 to 1524 882 to 1       882/882
(100 %)
8 diff
(99.1 %id)
FN086404 breast carcinoma .a 670 to 758 1 to 89       89/97
(91 %)
3 diff
(97.0 %id)
AL581150 T cells from T cell leukemia .a 677 to 1471 826 to 33       794/826
(96 %)
0 diff
(100 %id)
AL570104 placenta, Placenta Cot 25-normalized .a 690 to 1522 836 to 1   fully sequenced,   836/836
(100 %)
7 diff
(99.2 %id)
AA005026 liver and spleen .a 705 to 1108 1 to 407   fully sequenced,   407/407
(100 %)
11 diff
(97.3 %id)
AL581112 T cells from T cell leukemia .a 712 to 1499 767 to 1   fully sequenced,   767/767
(100 %)
57 diff
(92.6 %id)
BU597005 mixed (pool of 40 RNAs) .a 782 to 1399 1 to 630       630/862
(73 %)
27 diff
(96.9 %id)
N94603 senescent fibroblast .a 783 to 1197 418 to 1       418/418
(100 %)
4 diff
(99.1 %id)
AL525622 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 791 to 1524 734 to 1       734/827
(88 %)
2 diff
(99.8 %id)
CA421322 Bone, Enchondroma cell line .a 813 to 1528 733 to 19   AAA   715/715
(100 %)
2 diff
(99.8 %id)
R24174 placenta .a 819 to 1180 370 to 2       369/410
(90 %)
0 diff
(100 %id)
AL525423 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 821 to 1516 680 to 1   fully sequenced,   680/680
(100 %)
55 diff
(92.0 %id)
TI_149299973   .a 850 to 1528 770 to 93   AAA   678/678
(100 %)
1 diff
(99.9 %id)
BM976138 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 871 to 1528 675 to 19   AAA   657/657
(100 %)
1 diff
(99.9 %id)
AL527825 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 879 to 1518 629 to 1   fully sequenced,   629/629
(100 %)
3 diff
(99.6 %id)
AL578773 placenta .a 886 to 1500 614 to 1   fully sequenced,   614/614
(100 %)
6 diff
(99.1 %id)
BU684255 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 901 to 1536 653 to 19   AAA   635/635
(100 %)
1 diff
(99.9 %id)
CA413966 Chondrosarcoma Grade II, Left Pelvis .a 901 to 1531 648 to 19   AAA   630/630
(100 %)
3 diff
(99.6 %id)
AA304100 aorta .a 930 to 1200 1 to 271       271/271
(100 %)
1 diff
(99.7 %id)
AW247311.
matches multiple genes
lung, small cell carcinoma .a 965 to 1531 576 to 11   AAA also hits gene CHST10 566/566
(100 %)
3 diff
(99.5 %id)
CA310040 Bone, Enchondroma cell line .a 982 to 1533 569 to 19   AAA   551/551
(100 %)
2 diff
(99.7 %id)
AA057259 uterus .a 998 to 1233 1 to 242   fully sequenced,   242/242
(100 %)
4 diff
(98.4 %id)
BX330304 Placenta Cot 25-normalized .a 1003 to 1532 539 to 1       539/560
(96 %)
39 diff
(93.1 %id)
CB140336 Liver .a 1018 to 1513 1 to 496       496/496
(100 %)
10 diff
(98.0 %id)
AA700210 liver and spleen .a 1020 to 1548 524 to 1       524/524
(100 %)
5 diff
(99.1 %id)
AI830865 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1024 to 1532 508 to 1       508/508
(100 %)
2 diff
(99.7 %id)
BF220202 lung, small cell carcinoma .a 1050 to 1459 423 to 9       415/423
(98 %)
0 diff
(100 %id)
CB959146 Pooled-Glandular .a 1060 to 1526 14 to 480       467/490
(95 %)
4 diff
(99.2 %id)
BG056627 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .a 1066 to 1532 471 to 7       465/471
(98 %)
0 diff
(100 %id)
AI953770 brain, three pooled meningiomas .a 1067 to 1536 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
R61301 whole brain .a 1068 to 1528 477 to 12   AAA   466/468
(99 %)
18 diff
(96.2 %id)
AI758681 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1072 to 1528 456 to 1       456/460
(99 %)
1 diff
(99.8 %id)
BM990353 lung, Metastatic Chondrosarcoma .a 1074 to 1531 472 to 16   AAA   457/465
(98 %)
1 diff
(99.8 %id)
AA005027 liver and spleen .a 1078 to 1548 468 to 1   fully sequenced,   468/468
(100 %)
6 diff
(98.8 %id)
H02195 placenta .a 1097 to 1524 1 to 435       435/436
(99 %)
17 diff
(96.2 %id)
AA177114   .a 1105 to 1525 1 to 421       421/451
(93 %)
6 diff
(98.7 %id)
AW081198 colon, moderately differentiated adenocarcinoma .a 1106 to 1534 432 to 5       428/432
(99 %)
0 diff
(100 %id)
AW057754 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 1107 to 1533 426 to 1       426/426
(100 %)
7 diff
(98.4 %id)
AI308056 2 pooled tumors (clear cell type), Kidney .a 1108 to 1540 432 to 1       432/432
(100 %)
6 diff
(98.7 %id)
AA129677 lung, lung carcinoma .a 1110 to 1540 432 to 3       430/432
(99 %)
0 diff
(100 %id)
CN349707 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1114 to 1534 1 to 421       421/425
(99 %)
1 diff
(99.8 %id)
AA844328 parathyroid gland, parathyroid tumor .a 1115 to 1533 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
AI369606 anaplastic oligodendroglioma, brain .a 1119 to 1533 414 to 1       414/414
(100 %)
1 diff
(99.8 %id)
H16180 whole brain .a 1120 to 1540 437 to 3       435/439
(99 %)
0 diff
(100 %id)
AI074152 Kidney .a 1122 to 1533 422 to 12   AAA   411/411
(100 %)
6 diff
(98.6 %id)
BX113039 whole brain .a 1128 to 1536 423 to 15   AAA   409/409
(100 %)
2 diff
(99.6 %id)
BF062768 colon, colon tumor, RER+ .a 1128 to 1493 376 to 26       351/376
(93 %)
0 diff
(100 %id)
BF591983 Kidney .a 1129 to 1533 405 to 1       405/405
(100 %)
0 diff
(100 %id)
N99055 senescent fibroblast .a 1134 to 1542 395 to 1   fully sequenced,   395/395
(100 %)
8 diff
(98.0 %id)
AA126002 colon, tumor .a 1134 to 1531 426 to 22   AAA   405/424
(95 %)
13 diff
(97.0 %id)
AW235593 Kidney .a 1143 to 1539 398 to 1       398/398
(100 %)
2 diff
(99.5 %id)
AA595226 breast .a 1148 to 1529 382 to 1       382/382
(100 %)
0 diff
(100 %id)
BE677659 dorsal root ganglia .a 1160 to 1537 377 to 1       377/377
(100 %)
1 diff
(99.8 %id)
AI418149 brain, glioblastoma (pooled) .a 1162 to 1530 374 to 7       368/374
(98 %)
0 diff
(100 %id)
BG675238 skin .a 1173 to 1533 1 to 361   AAA   361/361
(100 %)
0 diff
(100 %id)
BF435411 pooled .a 1189 to 1535 351 to 6       346/351
(98 %)
0 diff
(100 %id)
AA058704 uterus .a 1203 to 1528 333 to 1   fully sequenced,   333/333
(100 %)
7 diff
(97.9 %id)
R45386 whole brain .a 1204 to 1540 342 to 4       339/354
(95 %)
0 diff
(100 %id)
AI675864 Prostate .a 1208 to 1536 329 to 1       329/329
(100 %)
0 diff
(100 %id)
BE673302 Prostate .a 1208 to 1536 339 to 11   AAA   329/329
(100 %)
0 diff
(100 %id)
BG528520 adenocarcinoma, Prostate .a 1220 to 1540 1 to 321       321/871
(36 %)
4 diff
(99.6 %id)
CA453360 mixed (pool of 40 RNAs) .a 1221 to 1536 1 to 315   AAA   315/315
(100 %)
3 diff
(99.1 %id)
AI203134 pooled germ cell tumors .a 1237 to 1537 301 to 3       299/301
(99 %)
0 diff
(100 %id)
AI357395 brain, glioblastoma (pooled) .a 1237 to 1533 311 to 16   AAA   296/296
(100 %)
1 diff
(99.7 %id)
AI718629 aorta .a 1256 to 1528 272 to 1       272/272
(100 %)
1 diff
(99.7 %id)
DB515239 testis .a 1290 to 1531 1 to 241     Submitted on the opposite strand 241/241
(100 %)
1 diff
(99.6 %id)
BX331882 Neuroblastoma Cot 25-normalized .a 1291 to 1517 226 to 1       226/226
(100 %)
1 diff
(99.6 %id)
Z38499 brain, total brain .a 1293 to 1536 243 to 1       243/243
(100 %)
1 diff
(99.6 %id)
AA744940 breast .a 1294 to 1533 251 to 12   AAA   240/240
(100 %)
0 diff
(100 %id)
EC477161 Prostate .a 1333 to 1448 1 to 110       110/110
(100 %)
7 diff
(93.7 %id)
AW261913 brain, three pooled meningiomas .a 1365 to 1530 166 to 1       166/166
(100 %)
0 diff
(100 %id)
EC557250 Prostate .a 1442 to 1525 1 to 83       83/89
(93 %)
2 diff
(97.8 %id)
BU732721 eye, optic nerve .b 1 to 588 15 to 602   tiling clone, Submitted on the opposite strand 588/602
(97 %)
0 diff
(100 %id)
AK027210 Human lung .b 112 to 2317 1 to 2210 C88L tiling clone, available from FLJ, AAA   2210/2210
(100 %)
8 diff
(99.7 %id)
AA668255   .b 139 to 540 396 to 1       396/396
(100 %)
10 diff
(97.5 %id)
AJ709435 heart .b 148 to 457 320 to 12     Submitted on the opposite strand 309/320
(96 %)
6 diff
(98.2 %id)
BM709347 eye, optic nerve .b 523 to 958 436 to 1     Submitted on the opposite strand 436/436
(100 %)
0 diff
(100 %id)
CR617844 Placenta Cot 25-normalized .c 1 to 1559 1 to 1559 exact tiling clone,   1559/1559
(100 %)
0 diff
(100 %id)
AL545868 placenta, Placenta Cot 25-normalized .c 1 to 817 1 to 808 exact fully sequenced,   808/808
(100 %)
5 diff
(99.4 %id)
BM798629 myeloma .c 84 to 437 1 to 355       355/355
(100 %)
2 diff
(99.5 %id)
BM761632 lymph node, stomach .c 89 to 680 1 to 592 exact     592/592
(100 %)
1 diff
(99.9 %id)
BM844840 lymph node, stomach .c 89 to 644 1 to 556 exact     556/556
(100 %)
1 diff
(99.9 %id)
BM845446 lymph node, stomach .c 89 to 648 1 to 558 exact     558/558
(100 %)
2 diff
(99.7 %id)
R23993 placenta .c 124 to 557 1 to 443 Q69A R70E Q71A C72V G73W ...     443/447
(99 %)
13 diff
(97.1 %id)
T35643 lung .c 131 to 368 1 to 239       239/239
(100 %)
1 diff
(99.6 %id)
AW956320   .c 132 to 793 1 to 662 exact     662/664
(99 %)
11 diff
(98.4 %id)
AL571426 placenta, Placenta Cot 25-normalized .c 787 to 1559 758 to 1   fully sequenced,   758/758
(100 %)
5 diff
(99.4 %id)
BI223372 cervical carcinoma cell line, cervix .d 1 to 770 1 to 769 H84D tiling clone,   769/769
(100 %)
9 diff
(98.9 %id)
AV649861 corresponding non cancerous liver tissue Gene DUSP14, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV726254 hypothalamus Gene DUSP14, variant not shown         Suspected internal deletion, this clone was ignored    
AI700016 pooled germ cell tumors Gene DUSP14, variant not shown         Suspected internal deletion, this clone was ignored    
BE379320 endometrium, adenocarcinoma cell line, uterus Gene DUSP14, variant not shown         This clone was ignored    
BI759057 pooled colon, kidney, stomach Gene DUSP14, variant not shown         Suspected internal deletion, this clone was ignored    
TI_57146199   Gene DUSP14, variant not shown         Suspected internal deletion, this clone was ignored    
BP269061 thyroid Gene DUSP14, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes I